Discovering protective CD8 T cell epitopes—no single immunologic property predicts it!

Pavlo Gilchuk(AstraZeneca (Japan)), Sebastian Joyce(Walther Cancer Foundation), Timothy Hill(Vanderbilt University), John T. Wilson(Vanderbilt University)

Current Opinion in Immunology

February 6, 2015

10.1016/j.coi.2015.01.013

Cited by 21

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2

|Nature|2020|1.2k

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

|Cell Host & Microbe|2020|1.2k

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

|Nature Medicine|2021|1k

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

|Nature Medicine|2020|543

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

|Cell|2021|409